Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma

Figure 2

Response to first-line systemic therapy regimens. Objective responses were seen with gemcitabine + docetaxel (8/31, 26%), gemcitabine (3/12, 25%), and doxorubicin-alkylator combinations (5/20, 25%). CR = complete response, PR = partial response, SD = stable disease, and PD = progressive disease.